The effort will be worthwhile because, should a role for RANKL/RANK be found in the genesis or progression of endometrial cancer, the possibility of using ad hoc anti-RANKL proteins might open a new area in prevention and treatment [6,16]. The gene discussed is TNFSF11; the disease is endometrial cancer.